SITC Cancer Immunotherapy CONNECT

Browse our other events


2025 Winter School

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

Register Today
2025 Spring Scientific

2025 Spring Scientific: Cellular Therapy for Solid Tumors

March 12–14, 2025 in San Diego, CA
& Virtually

SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to challenges that impede bringing these novel therapies to patients in need.

Register Today

Targets for Cancer IO: A Deep Dive

A Deep Dive into the Updated Status of Targeted Co-stimulation: Success of Failure

Thurs., Dec. 12 |12–2 p.m. EST | Webinar

Hear recent updates in novel translational and clinical studies of co-stimulatory domains and ligands, their mechanisms of action, and how manipulation of these pathways can potentially improve the anti-cancer immune response.

REGISTER NOW
2024 ESMO-SITC

ESMO Immuno-Oncology Congress 2024: SITC Primer & Collaborative Session

Join the Immunotherapy Primer and collaborative session Dec. 11 – 13 presented by SITC and ESMO at #ESMOImmuno24! Understand the core concepts of immuno-oncology therapies and gain expert insights on alternative T cell subsets and differentiation pathways.

Learn More and Register
2024 Medlive

Keep Pace with Changes to the NSCLC Immunotherapy Landscape!

Access SITC and Medlive's free CME education on non-small cell lung cancer (NSCLC) led by a panel of thoracic oncologists! Uncover key updates for advanced or metastatic NSCLC & patient-centered treatment strategies for special populations.

Watch Now

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events

 Read the Latest SITC News

The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest ...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, ...
This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients ...

 Latest Discussions

  • NCI Virtual Workshop - In Vivo Engineering of Immune Cells ( IVEIC ) for Cancer ...

    3 people like this.
  • The abstract submission site is NOW OPEN for 2025 SITC Spring Scientific ...

  • 2024 IOTOX Symposium

    The MD Anderson Internal Medicine Division and Cancer Medicine Division are ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family